Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer
MONTREAL — Ability Biotherapeutics, a biotechnology company advancing logic-gated antibody therapies for cancer and autoimmune diseases, today announced the appointment of Angèle Maki, PhD, as Chief Business Officer (CBO). Dr. Maki brings over 20 years of bio
(Financial Post, 2025-12-09T12:45:37Z)